PRESS RELEASE published on 03/06/2024 at 07:46, 2 years 4 months ago Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024 Heidelberg Pharma to present first efficacy data on HDP-101 and data from proprietary ADC technology platform at AACR Meeting 2024. Details of ATAC and ADC-based cancer therapies Clinical Trials Heidelberg Pharma ADC Technology AACR Meeting 2024 ATAC Therapies
BRIEF published on 03/04/2024 at 11:24, 2 years 4 months ago Heidelberg Pharma Secures Up to $115 Million in Royalty Financing from HealthCare Royalty Biopharmaceuticals Heidelberg Pharma HealthCare Royalty Royalty Financing ZircaixTM
BRIEF published on 03/04/2024 at 11:24, 2 years 4 months ago Heidelberg Pharma obtient jusqu'à 115 millions de dollars de financement en redevances auprès de HealthCare Royalty Heidelberg Pharma Redevance En Matière De Soins De Santé Financement Des Redevances ZircaixTM Produits Biopharmaceutiques
PRESS RELEASE published on 03/04/2024 at 11:19, 2 years 4 months ago Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement to purchase royalties from Telix Pharmaceuticals for Zircaix(TM) Biotech Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
BRIEF published on 03/04/2024 at 11:07, 2 years 4 months ago Heidelberg Pharma Secures Royalty Financing Deal Worth Up to $115 Million with HealthCare Royalty Oncology Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
BRIEF published on 03/04/2024 at 11:07, 2 years 4 months ago Heidelberg Pharma conclut un accord de financement de redevances d'une valeur pouvant atteindre 115 millions de dollars avec HealthCare Royalty Oncologie Heidelberg Pharma Zircaix Redevance En Matière De Soins De Santé Financement Des Redevances
PRESS RELEASE published on 03/04/2024 at 11:02, 2 years 4 months ago EQS-Adhoc: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement involves royalties from worldwide sales of Telix Pharmaceuticals' ZircaixTM Heidelberg Pharma HealthCare Royalty Royalty Financing Telix Pharmaceuticals ZircaixTM
PRESS RELEASE published on 11/02/2023 at 16:34, 2 years 8 months ago Heidelberg Pharma Presents New Clinical Data from its Lead Candidate HDP-101 at the ASH Annual Meeting 2023
PRESS RELEASE published on 10/12/2023 at 07:09, 2 years 9 months ago Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023
PRESS RELEASE published on 09/19/2023 at 07:11, 2 years 9 months ago Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101
Published on 07/14/2026 at 01:45, 6 hours 40 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 8 hours 24 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 9 hours 15 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 10 hours 50 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 12 hours 25 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 08:00, 25 minutes ago Coinsilium Group Limited: Predictive Labs Unveils Nijinn; Coinsilium Increases Strategic Investment and Accelerates Venture-Building Strategy
Published on 07/14/2026 at 07:47, 37 minutes ago EQS-Adhoc: DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen:
Published on 07/14/2026 at 07:30, 54 minutes ago REINET INVESTMENTS S.C.A. SHARE BUYBACK PROGRAMME – UPDATE 14 July 2026
Published on 07/13/2026 at 18:00, 14 hours 25 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 14 hours 25 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 14 hours 25 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026